A technology-transfer development project for the MENA region.
Company information NeuroMuse GmbH · c/o Abelia Wirtschaftsprüfung und Beratung AG, Dufourstrasse 49, 4052 Basel, Switzerland · UID CHE-344.882.117. Project M is a technology-transfer development concept and not a marketed product.
Privacy notice We process personal data in accordance with the revised Swiss Federal Act on Data Protection (revFADP) and, where applicable, the EU GDPR. We use your data only to answer your enquiry. We do not sell it. Our service providers for website hosting and email process it on our behalf. Contact ts@neuromuse-m.com for privacy requests.
Cookies & external services This website uses only strictly necessary cookies. No tracking, analytics, or third-party advertising services are active on this site.
Professional & Project M notices Project M is a development concept for professional pharmaceutical partners only. It does not constitute a product offer, medical advice, or a claim of regulatory approval. All development options are subject to evidence, classification, and local authority decisions. No fast-track or launch date is promised.
Website terms & accessibility All content is provided for informational purposes only. NeuroMuse GmbH makes no warranties regarding accuracy or completeness. We aim to make this website accessible. If you have difficulty using it, please contact ts@neuromuse-m.com.
© 2026 NeuroMuse GmbH · UID CHE-344.882.117 Last updated: 19 October 2026
